loadpatents
name:-0.015405893325806
name:-0.01664400100708
name:-0.01875114440918
Blaisdell; Thomas P. Patent Filings

Blaisdell; Thomas P.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Blaisdell; Thomas P..The latest application filed is for "benzodiazepine derivatives as rsv inhibitors".

Company Profile
17.13.13
  • Blaisdell; Thomas P. - Watertown MA
  • Blaisdell; Thomas P. - Brighton MA
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Benzodiazepine derivatives as RSV inhibitors
Grant 11,390,631 - Shook , et al. July 19, 2
2022-07-19
Heterocyclic compounds as RSV inhibitors
Grant 11,091,501 - Kim , et al. August 17, 2
2021-08-17
Processes for the preparation of benzodiazepine derivatives
Grant 10,906,895 - Kim , et al. February 2, 2
2021-02-02
Combination pharmaceutical agents as RSV inhibitors
Grant 10,881,666 - Shook , et al. January 5, 2
2021-01-05
Benzodiazepine derivatives as RSV inhibitors
Grant 10,865,215 - Shook , et al. December 15, 2
2020-12-15
Heterocyclic compounds as RSV inhibitors
Grant 10,851,115 - Kim , et al. December 1, 2
2020-12-01
Heterocyclic compounds as RSV inhibitors
Grant 10,759,816 - Yu , et al. Sep
2020-09-01
Aryldiazepine derivatives as RSV inhibitors
Grant 10,752,598 - Or , et al. A
2020-08-25
Benzodiazepine Derivatives As Rsv Inhibitors
App 20200223867 - Shook; Brian C. ;   et al.
2020-07-16
Azepin-2-one derivatives as RSV inhibitors
Grant 10,647,711 - Blaisdell , et al.
2020-05-12
Benzodiazepine derivatives as RSV inhibitors
Grant 10,570,153 - Shook , et al. Feb
2020-02-25
Processes For The Preparation Of Benzodiazepine Derivatives
App 20190308964 - Kim; In Jong ;   et al.
2019-10-10
Heteroaryldiazepine derivatives as RSV inhibitors
Grant 10,398,706 - Shook , et al. Sep
2019-09-03
Processes for the preparation of benzodiazepine derivatives
Grant 10,358,441 - Kim , et al.
2019-07-23
Combination Pharmaceutical Agents As Rsv Inhibitors
App 20190192535 - Shook; Brian C. ;   et al.
2019-06-27
Azepin-2-one Derivatives As Rsv Inhibitors
App 20190152968 - Blaisdell; Thomas P. ;   et al.
2019-05-23
Heterocyclic Compounds As Rsv Inhibitors
App 20190040084 - Yu; Jianming ;   et al.
2019-02-07
Heterocyclic Compounds As Rsv Inhibitors
App 20190002478 - Kim; In Jong ;   et al.
2019-01-03
Heterocyclic Compounds As Rsv Inhibitors
App 20190002479 - Kim; In Jong ;   et al.
2019-01-03
Aryldiazepine Derivatives As Rsv Inhibitors
App 20180354912 - Or; Yat Sun ;   et al.
2018-12-13
Benzodiazepine Derivatives As Rsv Inhibitors
App 20180258102 - Shook; Brian C. ;   et al.
2018-09-13
Processes For The Preparation Of Benzodiazepine Derivatives
App 20180237425 - Kim; In Jong ;   et al.
2018-08-23
Heteroaryldiazepine Derivatives As Rsv Inhibitors
App 20180193352 - Shook; Brian C. ;   et al.
2018-07-12
Benzodiazepine derivatives as RSV inhibitors
Grant 9,957,281 - Shook , et al. May 1, 2
2018-05-01
Heterocyclic Compounds As Rsv Inhibitors
App 20170226129 - Yu; Jianming ;   et al.
2017-08-10
Benzodiazepine Derivatives As Rsv Inhibitors
App 20170022221 - Shook; Brian C. ;   et al.
2017-01-26

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed